Postmortem chemistry update Part II

International Journal of Legal Medicine

Volumn 126, Issue 2, 2012, Pages 199-215

  Palmiere, Cristian ^a   Mangin, Patrice ^a  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

Author keywords

Anaphylaxis; Cardiac function; Inflammation; Liver function; Postmortem chemistry; Sepsis

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCITONIN; DIETHYL SULFATE; ETHYL GLUCURONIDE; GLUCURONIC ACID; HORMONE; PROCALCITONIN; PROTEIN PRECURSOR; SULFATE; TRANSFERRIN;

ALCOHOLISM; ANAPHYLAXIS; BLOOD; CADAVER; DRINKING BEHAVIOR; ENZYMOLOGY; FORENSIC PATHOLOGY; HEART DISEASE; HEART FUNCTION TEST; HUMAN; INFLAMMATION; LIVER; LIVER FUNCTION TEST; METABOLISM; METHODOLOGY; REVIEW; SEPSIS;

ALCOHOL DRINKING; ALCOHOLISM; ANAPHYLAXIS; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FORENSIC PATHOLOGY; GLUCURONATES; HEART DISEASES; HEART FUNCTION TESTS; HORMONES; HUMANS; INFLAMMATION; LIVER; LIVER FUNCTION TESTS; POSTMORTEM CHANGES; PROTEIN PRECURSORS; SEPSIS; SULFURIC ACID ESTERS; TRANSFERRIN;

EID: 84862987734     PISSN: 09379827     EISSN: 14371596     Source Type: Journal    
DOI: 10.1007/s00414-011-0614-1     Document Type: Review

References (154)

1. Kumar V (2009) Robbins and Cotran: pathologic basis of disease, 8th edn. Saunders, Philadelphia.
2. Finkbeiner WE, Ursell PC, Davis RL (2004) Autopsy pathology. A manual and atlas. Churchill Livingstone, Philadelphia.
3. Coe JI (1993) Postmortem chemistry update. Emphasis on forensic application. Am J Forensic Med Pathol 14(2): 91-117.
4. Särkioja T, Ylä-Herttuala S, Solakivi T, Nikkari T, Hirvonen J (1988) Stability of plasma total cholesterol, triglycerides and apolipoproteins B and A-1 during the early postmortem period. J Forensic Sci 33(6):1432-1438.
5. Uemura K, Shintani-Ishida K, Saka K, Nakajima M, Ikegaya H, Kikuchi Y, Yoshida K (2008) Biochemical blood markers and sampling sites in forensic autopsy. J Forensic Leg Med 15 (5):312-317.
6. Piette M, De Schrijver G (1987) Gamma-glutamyl transferase: applications in forensic pathology. I: study of blood serum recovered from human bodies. Med Sci Law 27(3): 152-160.
7. Sadler DW, Girela E, Pounder DJ (1996) Post mortem markers of chronic alcoholism. Forensic Sci Int 82(2):153-163.
8. Arndt T (2001) Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis and interpretation. Clin Chem 47(1):13-27.
9. Bortolotti F, De Paoli G, Tagliaro F (2006) Carbohydratedeficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001-2005. J Chromatogr B Analyt Technol Biomed Life Sci 841(1-2):96-109.
10. Rainio J, De Giorgio F, Bortolotti F, Tagliaro F (2008) Objective post-mortem diagnosis of chronic alcohol abuse-a review of studies on new markers. Leg Med (Tokyo) 10(5):229-235.
11. Delanghe JR, De Buyzere ML (2009) Carbohydrate deficient transferrin and forensic medicine. Clin Chim Acta 406(1-2):1-7.
12. Simonnet C, Dumestre-Toulet V, Kintz P, Gromb S (1999) Review of factors susceptible of influencing postmortem carbohydrate-deficient transferrin. Forensic Sci Int 106(1):7-17.
13. Malcolm R, Anton RF, Conrad SE, Sutherland S (1999) Carbohydrate- deficient transferrin and alcohol use in medical examiner cases. Alcohol 17(1):7-11.
14. Osuna E, Pérez-Cárceles MD, Moreno M, Bedate A, Conejero J, Abenza JM, Martínez P, Luna A (2000) Vitreous humor carbohydrate- deficient transferrin concentrations in the postmortem diagnosis of alcoholism. Forensic Sci Int 108(3):205-213.
15. Berkowicz A, Wallerstedt S, Wall K, Denison H (2001) Carbohydrate- deficient transferrin in vitreous humor: a marker of possible withdrawal-related death in alcoholics. Alcohol Alcohol 36(3):231-234.
16. Berkowicz A, Wallerstedt S, Wall K, Denison H (2003) Analysis of carbohydrate-deficient transferrin (CDT) in vitreous humor as a forensic tool for detection of alcohol misuse. Forensic Sci Int 137(2-3):119-124.
17. Rainio J, De Paoli G, Druid H, Kauppila R, De Giorgio F, Bortolotti F, Tagliaro F (2008) Postmortem stability and redistribution of carbohydrate-deficient transferrin (CDT). Forensic Sci Int 174(2-3):161-165.
18. Schmitt G, Droenner P, Skopp G, Aderjan R (1997) Ethyl glucuronide concentration in serum of human volunteers, teetotalers, and suspected drinking drivers. J Forensic Sci 42 (6):1099-1102.
19. Wurst FM, Kempter C, Seidl S, Alt A (1999) Ethyl glucuronide: a marker of alcohol consumption and a relapse marker with clinical and forensic implications. Alcohol Alcohol 34(1):71-77.
20. Wurst FM, Schüttler R, Kempter C, Seidl S, Gilg T, Jachau K, Alt A (1999) Can ethyl glucuronide be determined in postmortem body fluids and tissues? Alcohol Alcohol 34(2): 262-263.
21. Wurst FM, Kempter C, Metzger J, Seidel S, Alt A (2000) Ethyl glucuronide: a marker of recent alcohol consumption with clinical and forensic implications. Alcohol 20(2):111-116.
22. Alt A, Janda I, Seidl S, Wurst FM (2000) Determination of ethyl glucuronide in hair samples. Alcohol Alcohol 35(3):313-314.
23. Skopp G, Schmitt G, Pötsch L, Drönner P, Aderjan R, Mattern R (2000) Ethyl glucuronide in human hair. Alcohol Alcohol 35 (3):283-285.
24. Seidel S, Wurst FM, Alt A (2001) Ethyl glucuronide-a biological marker for recent alcohol consumption. Addict Biol 6(3):205-212.
25. Yegles M, Labarthe A, Auwärter V, Hartwig S, Vater R, Wennig R, Pragst F (2004) Comparison of ethyl glucuronide and fatty acid ethyl ester concentrations in hair of alcoholics, social drinkers and teetotallers. Forensic Sci Int 145(2-3):167-173.
26. Jurado C, Soriano T, Giménez MP, Menédez M (2004) Diagnosis of chronic alcohol consumption. Hair analysis for ethyl-glucuronide. Forensic Sci Int 145(2-3):161-166.
27. Schloegl H, Dresen S, Spaczynski K, Stoertzel M, Wurst FM, Weinmann W (2006) Stability of ethyl glucuronide in urine, post-mortem tissue and blood samples. Int J Legal Med 120 (2):83-88.
28. Schloegl H, Rost T, Schmidt W, Wurst FM, Weinmann W (2006) Distribution of ethyl glucuronide in rib bone marrow, other tissues and body liquids as proof of alcohol consumption before death. Forensic Sci Int 156(2-3):213-218.
29. Politi L, Zucchella A, Morini L, Stranesi C, Polettini A (2006) Markers of chronic alcohol use in hair: comparison of ethyl glucuronide and cocaethylene in cocaine users. Forensic Sci Int 172(1):23-27.
30. Politi L, Morini L, Leone F, Polettini A (2006) Ethyl glucuronide in hair: is it a reliable marker of chronic high levels of alcohol consumption? Addiction 101(10):1408-1412.
31. Høiseth G, Karinen R, Christophersen AS, Olsen L, Normann PT, Mørland J (2007) A study of ethyl glucuronide in postmortem blood as a marker of ante-mortem ingestion of alcohol. Forensic Sci Int 165(1):41-45.
32. Høiseth G, Karinen R, Johnsen L, Normann PT, Christophersen AS, Mørland J (2008) Disappearance of ethyl glucuronide during heavy putrefaction. Forensic Sci Int 176(2-3):147-151.
33. Kharbouche H, Sporkert F, Staub C, Mangin P, Augsburger M (2009) Ethyl glucuronide: a biomarker of alcohol consumption. Praxis 98(22):1299-1306 (Bern 1994).
34. Morini L, Politi L, Acito S, Groppi A, Polettini A (2009) Comparison of ethyl glucuronide in hair with carbohydratedeficient transferrin in serum as markers of chronic high levels of alcohol consumption. Forensic Sci Int 188(1-3):140-143.
35. Morini L, Politi L, Polettini A (2009) Ethyl glucuronide in hair. A sensitive and specific marker of chronic heavy drinking. Addiction 104(6):915-920.
36. Pragst F, Rothe M, Moench B, Hastedt M, Herre S, Simmert D (2010) Combined use of fatty acid ethyl esters and ethyl glucuronide in hair for diagnosis of alcohol abuse: interpretation and advantages. Forensic Sci Int 196(1-3):101-110.
37. Liniger B, Nguyen A, Friedrich-Koch A, Yegles M (2010) Abstinence monitoring of suspected drinking drivers: ethyl glucuronide in hair versus CDT. Traffic Inj Prev 11(2):123-126.
38. Høiseth G, Karinen R, Christophersen AS, Mørland J (2010) Practical use of ethyl glucuronide and ethyl sulfate in postmortem cases as markers of antemortem alcohol ingestion. Int J Legal Med 124(2):143-148.
39. Kronstrand R, Brinkhagen L, Nyström FH (2011) Ethyl glucuronide in human hair after daily consumption of 16 or 32 g of ethanol for 3 months. Forensic Sci Int. doi:10.1016/j. forsciint.2011.01.044.
40. Dahl H, Voltaire Carlsson A, Hillgren K, Helander A (2011) Urinary ethyl glucuronide and ethyl sulfate testing for detection of recent drinking in an outpatient treatment program for alcohol and drug dependence. Alcohol Alcohol 46(3):278-282.
41. Helander A, Olsson I, Dahl H (2007) Postcollection synthesis of ethyl glucuronide by bacteria in urine may cause false identification of alcohol consumption. Clin Chem 53(10): 1855-1857.
42. Wurst FM, Dresen S, Allen JP, Wiesbeck G, Graf M, Weinmann W (2006) Ethyl sulphate: a direct ethanol metabolite reflecting recent alcohol consumption. Addiction 101(2):204-211.
43. Baranowski S, Serr A, Thierauf A, Weinmann W, Grosse Perdekamp M, Wurst FM, Halter CC (2008) In vitro study of bacterial degradation of ethyl glucuronide and ethyl sulfate. Int J Legal Med 122(5):389-393.
44. Halter CC, Laengin A, Al-Ahmad A, Wurst FM, Weinmann W, Kuemmerer K (2009) Assessment of the stability of the ethanol metabolite athyl sulfate in standardized degradation tests. Forensic Sci Int 186(1-3):52-55.
45. Thierauf A, Serr A, Halter CC, Al-Ahmad A, Rana S, Weinmann W (2008) Influence of preservatives on the stability of ethyl glucuronide and ethyl sulphate in urine. Forensic Sci Int 182(1- 2):41-45.
46. Thierauf A, Kempf J, Grosse Perdekamp M, Auwärter V, Gnann H, Wohlfarth A, Weinmann W (2011) Ethyl sulphate and ethyl glucuronide in vitreous humor as postmortem evidence marker for ethanol consumption prior to death. Forensic Sci Int 210(1- 3):63-68.
47. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambahashi Y, Inouye K, Imura H (1991) Brain natriuretic peptide as a novel cardiac hormone in humans-evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87:1402-1412.
48. Dagnino L, Drouin J, Nemer M (1991) Differential expression of natriuretic peptide genes in cardiac and extracardiac tissues. Mol Endocrinol 5:1292-1300.
49. Takahashi T, Allen PD, Izumo S (1992) Expression of A-, B- and C-type natriuretic peptide genes in failing and developing human ventricles-correlation with expression of the Ca(2+)-ATPase gene. Circ Res 71:9-17.
50. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, Mukoyama M, Nakao K (1993) Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88:82-91.
51. Hill NS, Klinger JR, Warbuton RR, Pietras L, Wrenn DS (1994) Brain natriuretic peptide: possible role in the modulation of hypoxic pulmonary hypertension. Am J Physiol 266:308-315.
52. Yandle TG (1994) Biochemistry of natriuretic peptides. J Intern Med 235(6):561-576.
53. Ogawa Y, Nakao K (1995) Brain natriuretic peptide as a cardiac hormone in cardiovascular disorders. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis and management, vol 1. Raven, New York, pp 833-840.
54. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, Masuda I, Nakanishi K, Yoshimasa T, Hashimoto Y, Yamaguchi M, Hori R, Yasue H, Nakao K (1995) Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92 (6):1558-1564.
55. Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, Kangawa K, Matsuo H, Omae T, Matsuoka H (1996) Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 28:22-30.
56. Tanaka T, Hasegawa K, Fujita M, Tamaki SI, Yamazato A, Kihara Y, Nohara R, Sasayama S (1998) Marked elevation of brain natriuretic peptide levels in pericardial fluid is closely associated with left ventricular dysfunction. J Am Coll Cardiol 31(2):399-403.
57. Ruskoaho H (2003) Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 24(3):341-356.
58. Ala-Kopsala M, Ruskoaho H, Leppäluoto J, Seres L, Skoumal R, Toth M, Horkay F, Vuolteenaho O (2005) Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides. Clin Chem 51(4):708-718.
59. Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Tanaka S, Kamikodai Y, Tsuda K, Okazaki S, Maeda H (2007) Postmortem pericardial natriuretic peptides as markers of cardiac function in medico-legal autopsies. Int J Legal Med 121:28-35.
60. Michaud K, Augsburger M, Donzé N, Sabatasso S, Faouzi M, Bollmann M, Mangin P (2008) Evaluation of postmortem measurement of NT-proBNP as a marker for cardiac function. Int J Legal Med 122:415-420.
61. Osuna E, Pérez-Cárceles MD, Alvarez MV, Noguera J, Luna A (1998) Cardiac troponin I (cTn I) and the postmortem diagnosis of myocardial infarction. Int J Legal Med 111:173-176.
62. Ellingsen CL, Hetland Ø (2003) Serum concentrations of cardiac troponin T in sudden death. Am J Forensic Med Pathol 25 (3):213-215.
63. Davies SJ, Gaze DC, Collinson PO (2005) Investigation of cardiac troponins in postmortem subjects: comparing antemortem and postmortem levels. Am J Forensic Med Pathol 26 (3):213-215.
64. Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Oritani S, Kamikodai Y, Tsuda K, Okazaki S, Maeda H (2006) Postmortem cardiac troponin T levels in the blood and pericardial fluid. Part 1. Analysis with special regard to traumatic causes of death. Leg Med (Tokyo) 8(2):86-93.
65. Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Kamikodai Y, Tsuda K, Okazaki S, Maeda H (2006) Postmortem cardiac troponin T levels in the blood and pericardial fluid. Part 2: analysis for application in the diagnosis of sudden cardiac death with regard to pathology. Leg Med (Tokyo) 8(2):94-101.
66. Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Bessho Y, Kamikodai Y, Tsuda K, Okazaki S, Maeda H (2007) Postmortem cardiac troponin I and creatine kinase MB levels in the blood and pericardial fluid as markers of myocardial damage in medicolegal autopsy. Leg Med (Tokyo) 9(5):241-250.
67. Batalis NI, Marcus BJ, Papadea CN, Collins KA (2010) The role of postmortem cardiac markers in the diagnosis of acute myocardial infarction. J Forensic Sci 55(4):1088-1091.
68. Whang KT, Steinwald PM, White JC, Nylen ES, Snider RH, Simon GL, Goldberg RL, Becker KL (1998) Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab 83(9):3296-3301.
69. Maruna P, Nedelníková K, Gürlich R (2000) Physiology and genetics of procalcitonin. Physiol Res 49(Suppl 1):S57-S61.
70. Meisner M (2002) Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 323(1-2):17-29.
71. Becker KL, Nylén ES, White JC, Müller B, Snider RH (2004) Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 89 (4):1512-1525.
72. Becker KL, Snider R, Nyles ES (2008) Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitation. Crit Care Med 36(3):941-952.
73. Becker KL, Snider R, Nyles ES (2010) Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol 159(2):253-264.
74. Sudhir U, Venkatachalaian RK, Kumar TA, RaoMY, Kempegowda P (2011) Significance of serum procalcitonin in sepsis. Indian J Crit Care Med 15(1):1-5.
75. Tsokos M, Reichelt U, Nierhaus A, Püschel K (2001) Serum procalcitonin (PCT): a valuable biochemical parameter for the postmortem diagnosis of sepsis. Int J Legal Med 114(4-5): 237-243.
76. Ramsthaler F, Kettner M, Mall G, Bratzke H (2008) The use of rapid diagnostic test of procalcitonine serum levels for the postmortem diagnosis of sepsis. Forensic Sci Int 178(2-3): 139-145.
77. Tsokos M, Reichelt U, Jung R, Nierhaus A, Püschel K (2001) Interleukin-6 and C-reactive protein serum levels in sepsis-related fatalities during the early postmortem period. Forensic Sci Int 119 (1):47-56.
78. Uhlin-Hansen L (2001) C-reactive protein (CRP), a comparison of pre- and postmortem blood levels. Forensic Sci Int 124(1):32-35.
79. Fujita MQ, Zhu BL, Ishida K, Quan L, Oritani S, Maeda H (2002) Serum C-reactive protein levels in postmortem blood-an analysis with special reference to the cause of death and survival time. Forensic Sci Int 130(2-3):160-166.
80. Astrup BS, Thomsen JL (2007) The routine use of C-reactive protein in forensic investigations. Forensic Sci Int 172(1):49-55.
81. Maeda H, Zhu BL, Bessho Y, Ishikawa T, Quan L, Michiue T, Zhao D, Li DR, Komatsu A (2008) Postmortem serum nitrogen compounds and C-reactive protein levels with special regard to investigation of fatal hyperthermia. Forensic Sci Med Pathol 4 (3):175-180.
82. Ishikawa T, Hamel M, Zhu BL, Li DR, Zhao D, Michiue T, Maeda H (2008) Comparative evaluation of postmortem serum concentrations of neopterin and C-reactive protein. Forensic Sci Int 179(2-3):135-143.
83. Reichelt U, Jung R, Nierhaus A, Tsokos M (2005) Serial monitoring of interleukin-1β, soluble interleukin-2 receptor and lipopolysaccharide binding protein levels after death. A comparative evaluation of potential postmortem markers of sepsis. Int J Legal Med 119(2):80-87.
84. Schumann RR, Kirschning CJ, Unbehaun A, Aberle HP, Knope HP, Lamping N, Ulevitch RJ, Herrmann F (1996) The lipopolysaccharide-binding protein is a secretory class 1 acutephase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol 16(7):3490-3503.
85. Sakr Y, Burgett U, Nacul F, Reinhart K, Brunkhorst F (2008) Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis? Crit Care Med 36(7):2014-2022.
86. Schrag B, Roux-Lombard P, Schneiter D, Vaucher P, Mangin P, Palmiere C (2011) Evaluation of C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6 and interleukin- 8 as diagnostic parameters in sepsis-related fatalities. Int J Legal Med. doi:10.1007/s00414-011-0596-z.
87. Mimasaka S, Hashiyada M, Nata M, Funayama M (2001) Correlation between serum IL-6 levels and death: usefulness in diagnosis of "Traumatic shock"? Tohoku J Exp Med 193 (4):319-324.
88. Mimasaka S (2002) Postmortem cytokine levels and the cause of death. Tohoku J Exp Med 197(3):145-150.
89. Mimasaka S, Ohtsu Y, Tsunenari S, Funayama M (2006) Postmortem cytokine levels and severity of traumatic injuries. Int J Legal Med 120(5):265-270.
90. Mimasaka S, Funayama M, Hashiyada M, Nata M, Tsunenari S (2007) Significance of levels of IL-6 and IL-8 after trauma: a study of 11 cytokines post-mortem using multiplex immunoassay. Injury 38(9):1047-1051.
91. Hoffmann G, Wirleitner B, Fuchs D (2003) Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res 52(8):313-321.
92. Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, Bestetti A, Price RW, Fuchs D (2010) Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther 3:7-15.
93. Ambach E, Tributsch W, Fuchs D, Reibnegger G, Henn R, Wachter H (1991) Postmortem evaluation of serum and urine neopterin concentrations. J Forensic Sci 36(4):1089-1093.
94. Ambach E, Tributsch W, Rabl W, Fuchs D, Reibnegger G, Henn R, Wachter H (1991) Postmortem neopterin concentrations: comparison of diagnoses with and without cellular immunological background. Int J Legal Med 104(5):259-262.
95. Payne V, Kam CA (2004) Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia 59:695-703.
96. Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology (2005) The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 115:S483-S523.
97. Hogan AD, Schwartz LB (1997) Markers of mast cell degranulation. Methods 13(1):43-52.
98. Caughey GH (2006) Tryptase genetics and anaphylaxis. J Allergy Clin Immunol 117(6):1411-1414.
99. Edston E, van Hage-Hamsten M (1996) Tryptase-at last a useful diagnostic marker for anaphylactic death. Allergy 51 (6):443-445.
100. Edston E, van Hage-Hamsten M (1998) β-Tryptase measurements postmortem in anaphylactic deaths and in control. Forensic Sci Int 93(2-3):135-142.
101. Yunginger JW, Nelson DR, Squillace DL, Jones RT, Holley KE, Hyma BA, Schwartz LB (1991) Laboratory investigation of deaths due to anaphylaxis. J Forensic Sci 36(3):857-865.
102. Ansari MQ, Zamora JL, Lipscomb MF (1993) Postmortem diagnosis of acute anaphylaxis by serum tryptase analysis. A case report. Am J Clin Pathol 99(1):101-103.
103. Fineschi V, Monasterolo G, Rosi R, Turillazzi E (1999) Fatal anaphylactic shock during a fluorescein angiography. Forensic Sci Int 100(1-2):137-142.
104. Pumphrey RS, Roberts IS (2000) Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 53(4):273-276.
105. Konarzewski W, De'Ath S (2001) Unrecognised fatal anaphylactic reaction to propofol or fentanyl. Anaesthesia 56:497-498.
106. Way MG, Baxendine CL (2002) The significance of postmortem tryptase levels in supporting a diagnosis of anaphylaxis. Anaesthesia 57:310-311.
107. Riches KJ, Gillis D, James RA (2002) A autopsy approach to bee sting-related deaths. Pathology 34(3):257-262.
108. Edston E, van Hage-Hamsten M (2003) Death in anaphylaxis in aman with house dust mite allergy. Int J Legal Med 117(5):299-301.
109. Hitosugi M, Omura K, Yokoyama T, Kawato H, Motozawa Y, Nagai T, Tokudome S (2004) An autopsy case of fatal anaphylactic shock following fluorescein angiography: a case report. Med Sci Law 44(3):264-265.
110. Low I, Stables S (2006) Anaphylactic deaths in Auckland, New Zeland: a review of coronial autopsies from 1985 to 2005. Pathology 38(4):328-332.
111. Edston E, Eriksson O, van Hage-Hamsten M (2007) Mast cell tryptase in postmortem serum-reference values and confounders. Int J Legal Med 121(4):275-280.
112. Osawa M, Satoh F, Horiuchi H, Tian W, Kugota N, Hasegawa I (2008) Postmortem diagnosis of fatal anaphylaxis during intravenous administration of therapeutic and diagnostic agents: evaluation of clinical laboratory parameters and immunohistochemistry in three cases. Leg Med (Tokyo) 179(2-3):135-143.
113. Platt MS, Yunginger JW, Sekula-Perlman A, Irani AM, Smialek J, Mirchandani HG, Schwartz LB (1994) Involvement of mast cells in sudden infant death syndrome. J Allergy Clin Immunol 94:250-256.
114. Holgate S, Walters C, Walls AF, Lawrence S, Shell DJ, Variend S, Fleming PJ, Berry PJ, Gilbert RE, Robinson C (1994) The anaphylaxis hypothesis of sudden infant death syndrome (SIDS): mast cell degranulation in cot death revealed by elevated concentrations of tryptase in serum. Clin Exp Allergy 24:1115-1122.
115. Randall B, Butts J, Halsey F (1995) Elevated postmortem tryptase in the absence of anaphylaxis. J Forensic Sci 40:208-211.
116. Edston E, van Hage-Hamsten M (1997) Anaphylactoid shock-a common cause of death in heroin addicts? Allergy 52(9):950-954.
117. Edston E, Gidlund E, Wickman M, Ribbing H, van Hage- Hamsten M (1999) Increased mast cell tryptase in sudden infant death-anaphylaxis, hypoxia or artifact? Clin Exp Allergy 29 (12):1648-1654.
118. Fineschi V, Cecchi R, Centini F, Paglicci Reattelli L, Turillazzi E (2001) Immunohistochemical quantification of pulmonary mastcells and post-mortem blood dosages of tryptases and eosinophil cationic protein in 48 heroin-related deaths. Forensic Sci Int 120 (3):189-194.
119. Buckley MG, Variend S, Walls AF (2001) Elevated serum concentrations of beta-tryptase, but not alpha-tryptase, in sudden death infant syndrome. An investigation of anaphylactic mechanisms. Clin Exp Allergy 31(11):1696-1704.
120. Edston E, van Hage-Hamsten M (2003) Mast cell tryptase and hemolysis after trauma. Forensic Sci Int 131(1):8-13.
121. Nishio H, Suzuki K (2004) Serum tryptase levels in sudden infant death syndrome in forensic autopsy cases. Forensic Sci Int 139(1):57-60.
122. Horn KD, Halsey JF, Zumwalt RE (2004) Utilisation of serum tryptase and immunoglobulin E assay in the postmortem diagnosis of anaphylaxis. Am J Forensic Med Pathol 25(1):37-43.
123. Da Broi U, Moreschi C (2011) Post-mortem diagnosis of anaphylaxis: a difficult task in forensic medicine. Forensic Sci Int 204(1-3):1-5.
124. Mayer DE, Krauskopf A, Hemmer W, Moritz K, Jarisch R, Reitner C (2011) Usefulness of postmortem determination of serum tryptase, histamine and diamine oxidase in the diagnosis of fatal anaphylaxis. Forensic Sci Int. doi:10.1016/j.forsciint.2011.05.020.
125. Nishio H, Takai S, Miyazaki M, Horiuchi H, Osawa M, Uemura K, Yoshida K, Mukaida M, Ueno Y, Suzuki K (2005) Usefulness of serum mast cell-specific chymase levels for postmortem diagnosis of anaphylaxis. Int J Legal Med 119(6):331-334.
126. Ishikawa T, Quan L, Li DR, Zhao D, Michiue T, Hamel M, Maeda H (2008) Postmortem biochemistry and immunohistochemistry of adrenocorticotropic hormone with special regard to fatal hypothermia. Forensic Sci Int 179(2-3):147-151.
127. Ishikawa T, Miyaishi S, Tachibana T, Ishizu H, Zhu BL, Maeda H (2004) Fatal hypothermia related vacuolation of hormoneproducing cells in the anterior pituitary. Leg Med (Tokyo) 6 (3):157-163.
128. Müller E, Franke WG, Koch R (1997) Thyreoglobulin and violent asphyxia. Forensic Sci Int 90(3):165-170.
129. Senol E, Demirel B, Akar T, Gülbahar O, Bakar C, Bukan N (2008) The analysis of hormones and enzymes extracted from endocrine glands of the neck region in deaths due to hanging. Am J Forensic Med Pathol 29(1):49-54.
130. Edston E, Druid H, Holmgren P, Oström M (2001) Postmortem measurements of thyroid hormones in blood and vitreous humor combined with histology. Am J Forensic Med Pathol 22(1):78-83.
131. Dressler J, Mueller E (2006) High thyroglobulin (Tg) concentrations in fatal traumatic brain injuries. Am J Forensic Med Pathol 27(3):280-282.
132. Ishikawa T, Michiue T, Zhao D, Komatsu A, Azuma Y, Quan L, Hamel M, Maeda H (2009) Evaluation of postmortem serum and cerebrospinal fluid levels of thyroid-stimulating hormone with special regard to fatal hypothermia. Leg Med Tokyo 11(1): S228-S230.
133. Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Quan L, Oritani S, Bessho Y, Maeda H (2007) Postmortem serum catecholamine levels in relation to the cause of death. Forensic Sci Int 173 (2-3):122-129.
134. Wilke N, Janssen H, Fahrenhorst C, Hecker H, Manns MP, Brabant EG, Tröger HD, Breitmeier D (2007) Postmortem determination of concentrations of stress hormones in various body fluids-is there a dependency between adrenaline/noradrenaline quotient, cause of death and agony time? Int J Legal Med 121(5):385-394.
135. Ishikawa T, Yoshida C, Michiue T, Perdekamp MG, Pollak S, Maeda H (2010) Immunohistochemistry of catecholamine in the hypothalamic-pituitary-adrenal system with special regard to fatal hypothermia and hyperthermia. Leg Med (Tokyo) 12 (3):121-127.
136. Finlayson NB (1965) Blood cortisol in infants and adults: a postmortem study. J Pediatr 67:284-292.
137. Kubo S, Kitamura O, Orihara Y, Tsuda R, Hirose W, Nakasono I (1997) Isolated adrenocorticotropic hormone deficiency: an autopsy case of adrenal crisis. A case report. Am J Forensic Med Pathol 18 (2):202-205.
138. Al Sabri AM, Smith N, Busuttil A (1997) Sudden death due to auto-immune Addison's disease in a 12-year-old girl. Int J Legal Med 110(5):278-280.
139. Burke MP, Opeskin K (1999) Adrenocortical insufficiency. Am J Forensic Med Pathol 20(1):60-65.
140. Clapper A, Nashelsky M, Dailey M (2008) Evaluation of serum cortisol in the postmortem diagnosis of acute adrenal insufficiency. Am J Forensic Med Pathol 29(2):181-184.
141. Fanton L, Bévalot F, Cartiser N, Palmiere C, LeMeur C, Malicier D (2010) Postmortem measurement of human chorionic gonadotropin in vitreous humor and bile. J Forensic Sci 55(3):792-794.
142. Marsden JT (2006) Erythropoietin-measurement and clinical applications. Ann Clin Biochem 43:97-104.
143. Quan L, Zhu BL, Ishikawa T, Michiue T, Zhao D, Li DR, Ogawa M, Maeda H (2008) Postmortem serum erythropoietin levels in establishing the cause of death and survival time at medicolegal autopsy. Int J Legal Med 122(6):481-487.
144. Quan L, Zhu BL, Ishikawa T, Michiue T, Zhao D, Ogawa M, Maeda H (2010) Postmortemserum erythropoietin level as amarker of survival time in injury deaths. Forensic Sci Int 200(1-3): 117-122.
145. Yoshida C, Ishikawa T, Michiue T, Quan L, Maeda H (2011) Postmortem biochemistry and immunohistochemistry of chromogranin A as a stress marker with special regard to fatal hypothermia and hyperthermia. Int J Legal Med 125(1):11-20.
146. Li DR, Zhu BL, Ishikawa T, Zhao D, Michiue T, Maeda H (2006) Postmortem serum protein S100B levels with regard to the cause of death involving brain damage in medicolegal autopsy cases. Leg Med (Tokyo) 8(2):71-77.
147. Li DR, Zhu BL, Ishikawa T, Zhao D, Michiue T, Maeda H (2006) Immunohistochemical distribution of S-100 protein in the cerebral cortex with regard to the cause of death in forensic autopsy. Leg Med (Tokyo) 8(2):78-85.
148. Li DR, Michiue T, Zhu BL, Ishikawa T, Quan L, Zhao D, Yoshida C, Chen JH, Wang Q, Komatsu A, Azuma Y, Maeda H (2009) Evaluation of postmortem S100B levels in the cerebrospinal fluid with regard to the cause of death in medicolegal autopsy. Leg Med Tokyo 11(1):S273-S275.
149. Li DR, Ishikawa T, Quan L, Zhao D, Michiue T, Zhu BL, Wang HJ, Maeda H (2010) Morphological analysis of astrocytes in the hippocampus in mechanical asphyxiation. Leg Med (Tokyo) 12 (2):63-67.
150. Quan L, Ishikawa T, Hara J, Michiue T, Chen JH, Wang Q, Zhu BL, Maeda H (2011) Postmortem serotonin levels in cerebrospinal and pericardial fluids with regard to the cause of death in medicolegal autopsy. Leg Med (Tokyo) 13(2):75-78.
151. Musshoff F, Menting T, Madea B (2004) Postmortem serotonin (5-HT) concentrations in the cerebrospinal fluid of medicolegal cases. Forensic Sci Int 142(2-3):211-219.
152. Püschel K, Lockemann U, Bartel J (1995) Postmortem investigation of serum myoglobin levels with special reference to electrical fatalities. Forensic Sci Int 72(3):171-177.
153. Fieguth A, Schumann G, Tröger HD, Kleemann WJ (1999) The effect of lethal electrical shock on postmortem serum myoglobin concentrations. Forensic Sci Int 105(2):75-82.
154. Zhu BL, Ishida K, Quan L, Taniguchi M, Oritani S, Kamikodai Y, Fujita MQ, Maeda H (2001) Post-mortem urinary myoglobin levels with reference to the cause of death. Forensic Sci Int 115 (3):183-188.